DAVID ANDREW LINDENBERG D.O. NPI 1881909141

NPI Details

David Andrew Lindenberg, D.O. is a pain medicine physical medicine rehabilitation in Turlock, CA with 15 years of experience. The provider is a physician who provides a high level of care, either as a primary physician or consultant, for patients experiencing problems with acute, chronic or cancer pain in both hospital and ambulatory settings. Patient care needs may also be coordinated with other specialists. David Andrew Lindenberg, D.O. NPI is 1881909141. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1739 COLORADO AVE
TURLOCK, CA
ZIP 95382-714
Phone: (209) 448-3000
Fax: (209) 442-4116

The NPI 1881909141 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes (HCPCS:99152)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection of substance into lower spine canal using imaging guidance (HCPCS:62323)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64635)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64636)
• Injection of lower or sacral spine facet joint using imaging guidance, single level (HCPCS:64493)
• Injection of lower or sacral spine facet joint using imaging guidance, second level (HCPCS:64494)
• Injection of substance into middle or upper spine canal using imaging guidance (HCPCS:62321)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance (HCPCS:27096)
• Injection of upper or middle spine facet joint using imaging guidance, single level (HCPCS:64490)
• Injection of upper or middle spine facet joint using imaging guidance, second level (HCPCS:64491)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64633)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64634)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Fluoroscopic guidance for needle placement (HCPCS:77002)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level (HCPCS:64483)
• Insertion of spinal neurostimulator electrode array through skin (HCPCS:63650)
• Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance (HCPCS:64454)
• Destruction of nerve branches of knee using imaging guidance (HCPCS:64624)
• Training in the use of orthopedic device for arm, leg and/or trunk, each 15 minutes (HCPCS:97760)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Destruction of nerves supplying joint between spine and pelvis using imaging guidance (HCPCS:64625)
• Injection of anesthetic agent and/or steroid into spine and pelvis nerve using imaging guidance (HCPCS:64451)
• Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes (HCPCS:99153)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level (HCPCS:64484)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)

The enumeration date for this NPI number is 8/11/2010 and was last updated on 10/17/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: